- Home
- UNCY vs MGYR Comparison
UNCY vs MGYR Comparison
Compare UNCY & MGYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UNCY
- MGYR
- Stock Information
- Founded
- UNCY 2016
- MGYR 1922
- Country
- UNCY United States
- MGYR United States
- Employees
- UNCY N/A
- MGYR N/A
- Industry
- UNCY Biotechnology: Pharmaceutical Preparations
- MGYR Savings Institutions
- Sector
- UNCY Health Care
- MGYR Finance
- Exchange
- UNCY Nasdaq
- MGYR Nasdaq
- Market Cap
- UNCY 91.0M
- MGYR 98.9M
- IPO Year
- UNCY 2021
- MGYR 2006
- Fundamental
- Price
- UNCY $6.34
- MGYR $16.09
- Analyst Decision
- UNCY Strong Buy
- MGYR
- Analyst Count
- UNCY 4
- MGYR 0
- Target Price
- UNCY $6.38
- MGYR N/A
- AVG Volume (30 Days)
- UNCY 867.0K
- MGYR 9.7K
- Earning Date
- UNCY 08-13-2025
- MGYR 07-24-2025
- Dividend Yield
- UNCY N/A
- MGYR 1.60%
- EPS Growth
- UNCY N/A
- MGYR 19.38
- EPS
- UNCY N/A
- MGYR 1.43
- Revenue
- UNCY N/A
- MGYR $34,067,000.00
- Revenue This Year
- UNCY N/A
- MGYR N/A
- Revenue Next Year
- UNCY $1,458.53
- MGYR N/A
- P/E Ratio
- UNCY N/A
- MGYR $11.40
- Revenue Growth
- UNCY N/A
- MGYR 12.12
- 52 Week Low
- UNCY $2.02
- MGYR $10.67
- 52 Week High
- UNCY $11.00
- MGYR $16.31
- Technical
- Relative Strength Index (RSI)
- UNCY 48.29
- MGYR 72.48
- Support Level
- UNCY $4.70
- MGYR $15.69
- Resistance Level
- UNCY $7.58
- MGYR $16.16
- Average True Range (ATR)
- UNCY 1.20
- MGYR 0.19
- MACD
- UNCY -0.07
- MGYR -0.02
- Stochastic Oscillator
- UNCY 26.03
- MGYR 94.55
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.
About MGYR Magyar Bancorp Inc.
Magyar Bancorp Inc is a mid-tier stock holding company. The Company offers a full array of commercial and retail financial services, including the taking of time, savings and demand deposits; the making of commercial, consumer and home equity loans; and the provision of other financial services. The business consists of getting retail deposits from the general public in the areas surrounding the main office in New Brunswick, New Jersey and branch offices located in Middlesex and Somerset Counties, New Jersey, and investing those deposits, together with funds generated from operations and wholesale funding, in residential mortgage loans, home equity loans, home equity lines of credit, commercial real estate loans, commercial business loans, Small Business Administration loans.